Erythromelalgia in a Patient with Mast Cell Activation Syndrome: Response to Low Dose Naltrexone
Erythromelalgia is a rare condition that may be associated with a variety of underlying conditions and can be refractory to therapy. We report a case of a patient with mast cell activation syndrome (MCAS) who developed erythromelalgia and responded to low dose naltrexone (LDN).
Gespeichert in:
| Veröffentlicht in: | Skin (Milwood, N.Y.) N.Y.), 2020-05, Vol.4 (3), p.288-291 |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artikel |
| Sprache: | eng |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| Zusammenfassung: | Erythromelalgia is a rare condition that may be associated with a variety of underlying conditions and can be refractory to therapy. We report a case of a patient with mast cell activation syndrome (MCAS) who developed erythromelalgia and responded to low dose naltrexone (LDN). |
|---|---|
| ISSN: | 2574-1624 2574-1624 |
| DOI: | 10.25251/skin.4.3.15 |